Innate Pharma S.A. (OTCMKTS:IPHYF – Get Free Report) was the recipient of a significant decrease in short interest during the month of August. As of August 15th, there was short interest totalling 6,200 shares, a decrease of 8.8% from the July 31st total of 6,800 shares. Based on an average daily volume of 500 shares, the short-interest ratio is currently 12.4 days.
Innate Pharma Stock Up 9.5 %
IPHYF stock opened at $2.30 on Monday. Innate Pharma has a 12 month low of $1.93 and a 12 month high of $3.00. The firm’s 50-day moving average is $2.12 and its 200 day moving average is $2.38.
About Innate Pharma
Featured Articles
- Five stocks we like better than Innate Pharma
- Golden Cross Stocks: Pattern, Examples and Charts
- Autodesk Stock: Analysts’ Top AI Pick You Shouldn’t Overlook
- Transportation Stocks Investing
- Hidden Opportunities in Li Auto’s Tough Quarter You Can’t Miss
- How to Use the MarketBeat Excel Dividend Calculator
- Don’t Overlook Campbell Soup: Here’s What Could Drive Its Stock
Receive News & Ratings for Innate Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innate Pharma and related companies with MarketBeat.com's FREE daily email newsletter.